You are here: Industry Insights > IAVI

News List

Injection of optimism as HIV vaccine trial begins pharmatimes
January 28, 2022
The first doses of an experimental HIV vaccine have been delivered in a phase 1 clinical trial. International AIDS Vaccine Initiative (IAVI), a non-profit scientific...
Zendal and IAVI Partner for TB Vaccine Candidate americanpharmaceuticalreview
July 15, 2021
Biofabri and IAVI announced their intention to partner on efficacy trials of tuberculosis (TB) vaccine candidate, MTBVAC.
Batavia Manufactures IAVI’s Lassa Fever Vax Candidate contractpharma
July 15, 2021
Batavia Biosciences has successfully produced vaccine material for a Phase I clinical trial of IAVI’s Lassa fever vaccine candidate, rVSV∆G-LASV-GPC.
Novel HIV vaccine approach shows promise in “landmark” first-in-human trial europeanpharmaceuticalreview
February 07, 2021
The vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV and various other viral diseases.
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs pharmatimes
October 26, 2020
German pharma company Merck KGaA has partnered with non-profit scientific research organisation IAVI and Serum Institute of India to develop monoclonal antibodies (mAbs) for COVID-19.
IAVI, Merck KGaA and Serum Institute partner to develop COVID-19 mAbs expresspharma
October 23, 2020
The partnership aims to ensure access to a class of innovative therapies that have, to date, been out of reach in low- and middle-income countries (LMICs).
Merck joins race to develop Covid-19 vaccines and drugs pharmaceutical-technology
May 27, 2020
Merck (MSD) has joined the race to develop vaccines and treatments against Covid-19 with separate agreements with Themis, IAVI and Ridgeback Biotherapeutics.
Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever b3cnewswire
December 13, 2018
Batavia Biosciences announces today that the International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine.
IAVI Announces Clinical Trial of HIV Vaccine Candidate americanpharmaceuticalreview
October 12, 2018
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a first step in the generation of potent proteins, known as
IAVI Announces Clinical Trial of HIV Vaccine Candidate americanpharmaceuticalreview
October 10, 2018
The International AIDS Vaccine Initiative (IAVI) announces the start of a Phase I clinical trial (IAVI G001) to test a novel vaccine candidate designed to stimulate the immune system to initiate a first step in the generation of potent proteins...